SOPHiA GENETICS (SOPH) Net Cash Flow (2020 - 2026)

SOPHiA GENETICS has disclosed Net Cash Flow across 7 years of filings, most recently posting $43.8 million for Q2 2026.

• In Q2 2026, Net Cash Flow rose 83.67% year-over-year to $43.8 million; the TTM figure through Jun 2026 stood at $13.9 million (up 208.99% YoY), while the FY2025 annual figure was -$14.2 million, up 63.51% from the prior year.
• Net Cash Flow came in at $43.8 million for Q2 2026 at SOPHiA GENETICS, up from -$4.6 million in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $43.8 million in Q2 2026 to a low of -$20.8 million in Q3 2022.
• Average Net Cash Flow over 5 years is -$4.8 million, with a median of -$10.8 million recorded in 2023.
• Year-over-year, Net Cash Flow sank 1915.5% in 2023 and jumped 1596.8% in 2025.
• Over 5 years, Net Cash Flow stood at $587000.0 in 2022, then slumped by 1915.5% to -$10.7 million in 2023, then fell by 21.54% to -$13.0 million in 2024, then climbed by 7.13% to -$12.0 million in 2025, then jumped by 464.53% to $43.8 million in 2026.
• Per Business Quant data, the three most recent Net Cash Flow figures were $43.8 million in Q2 2026, -$4.6 million in Q1 2026, and -$12.0 million in Q4 2025.